CoChat

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials

Open access
van den Berg, Leonard H., Sorenson, Eric, Gronseth, Gary, Macklin, Eric A., Andrews, Jinsy, Baloh, Robert H., Benatar, Michael, Berry, James D., Chio, Adriano, Corcia, Philippe, Genge, Angela, Gubitz, Amelie K., Lomen-Hoerth, Catherine, McDermott, Christopher J., Pioro, Erik P., Rosenfeld, Jeffrey, Silani, Vincenzo, Turner, Martin R., Weber, Markus, Brooks, Benjamin Rix, Miller, Robert G., Mitsumoto, Hiroshi, for the Airlie House ALS Clinical Trials Guidelines Group · 2019 · Neurology
Cited by 140

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To revise the 1999 Airlie House consensus guidelines for the design and implementation of preclinical therapeutic studies and clinical trials in amyotrophic lateral sclerosis (ALS). METHODS: A consensus committee comprising 140 key members of the international ALS community (ALS researchers, clinicians, patient representatives, research funding representatives, industry, and regulatory agencies) addressed 9 areas of need within ALS research: (1) preclinical studies; (2) biological and phenotypic heterogeneity; (3) outcome measures; (4) disease-modifying and symptomatic interventions; (5) recruitment and retention; (6) biomarkers; (7) clinical trial phases; (8) beyond traditional trial designs; and (9) statistical considerations. Assigned to 1 of 8 sections, committee members generated a draft set of guidelines based on a "background" of developing a (pre)clinical question and a "rationale" outlining the evidence and expert opinion. Following a 2-day, face-to-face workshop at the Airlie House Conference Center, a modified Delphi process was used to develop draft consensus research guidelines, which were subsequently reviewed and modified based on comments from the public. Statistical experts drafted a separate document of statistical considerations (section 9). RESULTS: In this report, we summarize 112 guidelines and their associated backgrounds and rationales. The full list of guidelines, the statistical considerations, and a glossary of terms can be found in data available from Dryad (appendices e-3-e-5, doi.org/10.5061/dryad.32q9q5d). The authors prioritized 15 guidelines with the greatest potential to improve ALS clinical research. CONCLUSION: The revised Airlie House ALS Clinical Trials Consensus Guidelines should serve to improve clinical trial design and accelerate the development of effective treatments for patients with ALS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000007242

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 140

Metadata

Authors
van den Berg, L. H., Sorenson, E., Gronseth, G., Macklin, E. A., Andrews, J., Baloh, R. H., Benatar, M., Berry, J. D., Chio, A., Corcia, P., Genge, A., Gubitz, A. K., Lomen-Hoerth, C., McDermott, C. J., Pioro, E. P., Rosenfeld, J., Silani, V., Turner, M. R., Weber, M., Brooks, B. R., Miller, R. G., Mitsumoto, H., & for the Airlie House ALS Clinical Trials Guidelines Group
Venue
Neurology
Published
2019-04-02
Volume
92
Issue
14
Pages
e1610-e1623
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2921595875
Cited by
140
References
5
FWCI
13.57
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. https://app.cochat.ai/papers/10.1212/wnl.0000000000007242
The paper
van den Berg, L. H., Sorenson, E., Gronseth, G., Macklin, E. A., Andrews, J., Baloh, R. H., Benatar, M., Berry, J. D., Chio, A., Corcia, P., Genge, A., Gubitz, A. K., Lomen-Hoerth, C., McDermott, C. J., Pioro, E. P., Rosenfeld, J., Silani, V., Turner, M. R., Weber, M., . . . for the Airlie House ALS Clinical Trials Guidelines Group. (2019). Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology. https://doi.org/10.1212/wnl.0000000000007242

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.